The Sato Lab (Kei Sato) Profile picture
Oct 10, 2022 16 tweets 6 min read Read on X
BREAKING🔔 The 14th paper from G2P-Japan🇯🇵 is out at Cell Host & Microbe @cellhostmicrobe. #Omicron BA.2.75 (aka #Centaurus) seems to be more contagious than BA.5 and more pathogenic than the original BA.2. Please RT. 1/16
cell.com/cell-host-micr…
BA.2.75, emerged in India🇮🇳, is classified as VOC-LUM (variant of concern linage under monitoring) by WHO on July 7. Here we elucidated the transmissibility, sensitivity to antiviral immunity & drugs, and intrinsic pathogenicity of BA.2.75. 2/16
who.int/activities/tra…
BA.2.75 is a descendant of BA.2. However, BA.2.75 is phylogenetically different from BA.5, the currently predominant BA.2 descendant. BA.2.75 spike bears nine substitutions, but only a substitution is shared with BA.5 spike. 3/16 Image
First, our mathematical/statistical analysis revealed that the effective reproduction number ("Re" in the figure) of BA.2.75 is greater than that of BA.5. 4/16 Image
Second, we performed neutralization assay. we showed that:
1⃣ Resistance to 3rd-dose vaccine sera: BA.2.75 = BA.2. 5/16 Image
2⃣ Resistance to 4th-dose vaccine sera: BA.2.75 > BA.2 (1.7-fold). 6/16 Image
3⃣ Resistance to breakthrough BA.1/BA.2 infection sera: BA.2.75 = BA.2. 7/16 Image
4⃣ Resistance to breakthrough BA.5 infection sera: BA.2.75 > BA.5 (1.7-fold). 8/16 Image
5⃣ Resistance to BA.5-infected hamster sera: BA.2.75 >> BA.5 (11-fold!). 9/16 Image
6⃣ Resistance to BA.2.75-infected hamster sera: BA.2.75 << BA.5 (6.4-fold!), suggesting that BA.2.75 is immunogenetically different from BA.5. 10/16 Image
7⃣ We further evaluated the efficacy of 10 therapeutic monoclonal antibodies against BA.2.75. FYI, please see the following thread↓ 11/16
Image
Antiviral activity of three drugs, Remdesivir, Molnupiravir (EIDD-1931) and Paxlovid (Nirmatrelvir) against BA.2.75 was also evaluated. All 3 drugs were effective against BA.2.75. 12/16 Image
We solved the structure of BA.2.75 spike by cryo-electron microscopy and showed how BA.2.75 spike exhibits very high affinity to human ACE2 receptor. 13/16 ImageImage
Like BA.5 spike, BA.2.75 spike is highly fusogenic than BA.2. 14/16 Image
Using clinical isolates of BA.2, BA.2.75, BA.2 & Delta and a hamster model, we demonstrated that the intrinsic pathogenicity of BA.2.75 is comparable to that of BA.5 but is greater than that of the original BA.2. 15/16 Image
▶️ Our multiscale investigations suggest that BA.2.75 acquired virological properties independently of BA.5, and the potential risk of BA.2.75 to global health may be greater than that of BA.5. 16/16 Image

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with The Sato Lab (Kei Sato)

The Sato Lab (Kei Sato) Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @SystemsVirology

Jul 17
#拡散希望 速報🔔 G2P-Japan🇯🇵の新しい研究成果「新型コロナウイルス変異株KP.3.1.1のウイルス学的特性の解明」について、プレプリント公開に先立って速報します。本研究では、最近いくつかの国で増加傾向にある、JN.1の子孫株である新しい変異株KP.3.1.1の特性を検証しました。1/
春になり、JN.1の子孫株が出現し、それらが優勢になり始めています。現在本邦は第11波に入っていますが、それはこれらのJN.1の子孫株によって引き起こされています。現在の流行状況などについては、本日公開の最新コラムで解説しています↓ 2/
そのひとつ、KP.2 (JN.1.11.1.2)については、すでにG2P-Japan🇯🇵が論文として報告しています。3/
Read 10 tweets
Jul 17
BREAKING🔔 Here I want to quickly report our new results from G2P-Japan🇯🇵 before the preprint publication. We have elucidated the virological characteristics of SARS-CoV-2 KP.3.1.1 - a progeny of JN.1. Please RT🔥 1/
Cf.1 A new one, KP.2 (JN.1.11.1.2), has been already elucidated. 2/
Cf.2 Another new ones, KP.3 (JN.1.11.1.3), LB.1 (JN.1.9.2.1) and KP.2.3 (JN.1.11.1.2.3), have also been already elucidated. 3/
Read 8 tweets
Jun 6
#拡散希望 速報🔔 G2P-Japan🇯🇵の新しい研究成果「新型コロナウイルス変異株KP.3, LB.1, KP.2.3のウイルス学的特性の解明」について、プレプリント公開に先立って速報します。本研究では、最近いくつかの国で増加傾向にある、JN.1の子孫株である新しい3つの変異株の特性を検証しました。1/
春になり、JN.1の子孫株が出現し、それらが優勢になり始めています。そのひとつ、KP.2 (JN.1.11.1.2)の特性については、すでにG2P-Japan🇯🇵が論文として報告しています。2/
今回着目したのは、KP.2にやや遅れて出現した3つの株、KP.3 (JN.1.11.1.3)、LB.1 (JN.1.9.2.1)、KP.2.3 (JN.1.11.1.2.3)です。それぞれ、こんな変異を持っています。
(*参考まで、JN.1=BA.2.86.1.1で、BA.2.86系統の子孫株)3/ Image
Read 8 tweets
Jun 6
BREAKING🔔 Here I want to quickly report our new results from G2P-Japan🇯🇵 before the preprint publication. We have elucidated the virological characteristics of SARS-CoV-2 KP.3, LB.1 and KP.2.3 - progeny of JN.1. Please RT🔥 1/
Cf. A new one, KP.2 (JN.1.11.1.2), has been already elucidated. 2/
Here we focused on relatively new ones, KP.3 (JN.1.11.1.3), LB.1 (JN.1.9.2.1) and KP.2.3 (JN.1.11.1.2.3). These variants harbor these mutations⬇️ 3/ Image
Read 7 tweets
May 20
#拡散希望 第2回新型コロナウイルス研究集会を、8月2日〜4日に東京・品川で開催します! 今年のテーマは「COVID-19の疫学、臨床医学、免疫学、ウイルス学」。新型コロナに関する科学のすべてを網羅した集会になるよう準備を進めています! 1/
confit.atlas.jp/guide/event/co…
参加・演題登録はこちらから↓
今年は「オンデマンド配信」も予定しています。先約があったり、遠方で現地参加が難しい方や、医療従事者のみなさまにも広くご参加いただき、新型コロナの科学の最先端を知る機会を提供できればと思っています。2/
confit.atlas.jp/guide/event/co…
今年は、G2P-Japanが基礎ウイルス学を担当し、免疫学を⾼橋宜聖先生(感染研)、臨床医学を忽那賢志先生(阪⼤)@kutsunasatoshi 、公衆衛生学を押⾕仁(東北⼤)に担当いただきます。3/
confit.atlas.jp/guide/event/co…
Read 5 tweets
Apr 27
BREAKING🔔 A new study from G2P-Japan🇯🇵 is out at bioRxiv @biorxivpreprint. We elucidated the virological characteristics of SARS-CoV-2 KP.2 - a progeny of JN.1. Please RT🔥 1/
biorxiv.org/cgi/content/sh…
Cf. This is KP.2 (aka JN.1.11.1.2). In spike, KP.2 = JN.1 + S:R346T, S:F456L & S:V1104L).

We remember that R346T was observed in BQ.1.1 and XBB lineages, while F456L is a hallmark of EG.5 lineage. 2/ Image
Transmissibility/fitness (Re): molecular phylogenetic-epidemic dynamics modeling led by Jumpei @jampei2 and Kaho showed that the Re of KP.2 is ~1.2-fold greater than that of JN.1. 3/
Image
Image
Read 6 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(